Physicians are looking for better ways to treat patients with congestive heart failure. This includes the integration of remote monitoring and novel technologies.
Its success lies in a synergy between the technological and the clinical.
The deal will strengthen Stryker’s portfolio of smart technologies in its joint replacement business and provide products that help physicians make data-driven decisions.
Medically focused AR technology helps visualize, train and treat, even from a distance.
Monitoring patients through distributed technology will be key to restoring its health.
During the current operating environment there has been an increased need for healthcare training using patient simulators for students and practicing healthcare professionals.
In general, the Asian markets have controlled the COVID-19 virus successfully outside of China, but its effect has still led to new developments and trends.
Across our industry, IoMT will enable us to conduct research in ways that would never previously have been possible.
With everything to gain, telehealth may lead to a new standard in health/wellness treatment while at the same time unifying the entire healthcare ecosystem.
Medtech companies will need to collaborate more closely with other parties in healthcare, as the aftermath of the coronavirus pandemic will have a comprehensive reach throughout the entire ecosystem. MTI speaks with Johnson & Johnson VP Raymond Fryrear, M.D. on the topic.
